- Cotopaxi Drugs joins 11 Walgreens stores that have closed in the last three years due to rising crime in San Francisco. HT: CTUP
- Study: After a nuclear accident, Japan shut down all its nuclear reactors. That led to an increase in energy prices and that led to more deaths.
- Every time a drug switches from prescription to OTC, the total number of doctor visits drops.
- Does earlier detection of lung cancer lead to better survival: Here’s why we don’t know.
- David Friedman on Black Reparations and other issues. Recommended.
- Tyler Cowen: “Single parent families can be disastrous. In Colombia the current rate of that is 84 (!) percent. In Argentina, Mexico, and Chile it is more than half. For India I see estimates ranging from 4.5 percent to 7.5 percent for single parent families.”
Surgeon General Believes Toxic Workplaces are a Public Health Hazard (Seriously?)
It seems in recent years that the definition of public health has grown to include a lot of things seemingly unrelated to public health. The age-old definition of public health includes combating infectious disease and communicable illnesses. Covid-19 is definitely something that can be passed around, as is influenza. Attempts to control the spread of deadly pathogens falls well within the area of public health.
Friday Links
- Tyler Cowen compares Classical Liberalism with the New Right.
- The nation’s capital now has an estimated 120 homeless tent cities and their growth shows no signs of slowing down.
- Uber Eats to deliver marijuana in Canada.
- More details on the lab-created (and much more dangerous) omicron virus. Are scientists playing Russian roulette?
- ARPA is the protégé of DARPA – aimed at game changing innovations in medicine.
- Our health care data infrastructure is broken. What difference does that make?
FDA Panel Recommends Withdrawing Premature Birth Drug
An advisory panel for the U.S. Food and Drug Administration (FDA) voted to recommend revoking approval for a synthetic hormone called Makena. Makena is an obstetrics drug administered as a weekly injection to pregnant women at high risk of premature delivery.
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.
The recommendation, in a 14-1 vote, from the agency’s Obstetrics, Reproductive and Urologic Drugs Advisory Committee closed a three-day meeting on the clinical trial evidence supporting Makena, the only drug approved in the U.S. to prevent preterm births.